Skip to content

Meaning-Centered Psychotherapy in Advanced Cancer

Meaning-Centered Psychotherapy in Advanced Cancer

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00067288
Enrollment
118
Registered
2003-08-15
Start date
2002-05-31
Completion date
2006-03-31
Last updated
2006-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoma, Non-Hodgkin, Neoplasms

Keywords

Stage 3 cancer;, Stage 4 cancer;, solid tumor cancer;, Non-Hodgkin's Lymphoma;, solid tumors;, end-stage cancer;, group psychotherapy;, psychotherapy;, emotional support;, support groups

Brief summary

We have developed an 8-week Meaning-Centered Group Psychotherapy designed to help patients with advanced cancer sustain or enhance a sense of meaning, peace and purpose despite the limitations of their cancer illness. This project's overall aim is to explore the feasibility and efficacy of this new and unique psychotherapy intervention for advanced cancer patients in enhancing psychological and spiritual well-being and quality of life by comparing it with a standard supportive group psychotherapy.

Detailed description

As per Brief Summary

Interventions

BEHAVIORALMeaning-Centered Group Psychotherapy
BEHAVIORALStandard Supportive Group Psychotherapy

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
ECT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 21 years of age or older; * English speaking; * Stage III or IV solid-tumor or Non-Hodgkin's Lymphoma; * Receiving ambulatory care at Memorial Sloan-Kettering Cancer Center in New York City;

Exclusion criteria

* Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a group-format intervention; * Presence of cognitive impairment disorder, such as delirium or dementia that is sufficient, in the investigator's opinion, to preclude meaningful participation and/or informed consent; * Karnofsky Performance Rating Scale below 50 or physical limitations or illness severity sufficient to preclude participation in outpatient group psychotherapy.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026